The BCR/ABL oncoprotein encoded by the BCR/ABL oncogene maintains constitutive tyrosine kinase activity, induces downstream signalling pathway activation, promotes CML cell proliferation and inhibits cell apoptosis [2]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.